ArticleFrontiers in sleep2025
Prevalence and determinants of high-risk obstructive sleep apnea among hypertensive patients in referral hospitals of the Amhara Region, Northwest Ethiopia, 2022.
Article in Frontiers in sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea results from intermittent airway collapse during sleep. Despite its health risks, the prevalence and associated factors of OSA among hypertensive patients in Ethiopia remain unexplored. Objective: This study assessed the prevalence and associated factors of high-risk OSA among hypertensive patients in referral hospitals within the Amhara Region, Northwest Ethiopia, in 2022. Methods: A cross-sectional study was conducted in selected referral hospitals from 21 April to 14 June 2022. A systematic random sampling technique was employed. Data were collected through structured, pretested, interviewer-administered questionnaires, file reviews, and physical examinations. Data were entered in Epi-Data 4.6 and analyzed using Stata 14. Logistic regression was performed, and variables with Results: Of the 412 participants (97% response rate), the mean age was 58.95 ± 12.6 years, with 55.1% being female. The prevalence of high-risk OSA was determined to be 43.93% (95% CI: 39.2-48.8). Significant factors included age > 65 years (AOR = 8.00, 95% CI: 4.48-14.14), diabetes mellitus (AOR = 4.7, 95% CI: 2.48-8.94), male sex (AOR = 4.2, 95% CI: 2.38-7.45), and large neck circumference (AOR = 3.13, 95% CI: 1.27-7.74). Conclusion: High-risk OSA is prevalent among hypertensive patients, particularly in older males and those with diabetes or a large neck circumference. Routine OSA screening should be integrated into hypertension care. Future studies should utilize gold-standard tools and explore cause-and-effect relationships.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.